Numinus Wellness reports Q2 results
- Numinus Wellness press release (OTCQX:NUMIF): Q2 cash position of C$6.6 million as of February 29, 2024.
- Revenue of C$5M (-6.5% Y/Y).
- Enrolment in Numinus training programs doubled to over 1,400 learners, compared to over 700 in Q1 2024.
- Managed 15 clinical trials at Cedar Clinical Research.
- Provided 17,661 client appointments in Numinus Wellness Clinics.
- Numinus ended the quarter with a total cash balance of C$6.6 million and working capital of C$6.4 million.
